1. Introduction: Features of Helminth-Induced Immune Responses {#sec1}
==============================================================

Helminths have developed a unique evolutionary dialogue with their hosts\' immune system due to their longevity within the host, their complex life cycles, and multicellular nature. These pathogens induce very different immune responses in comparison to bacteria, fungi, viruses, or protozoa. Cells of the innate and adaptive immune system are important for the initiation of type 2 immunity, which characterises the response to helminth infection, as well as allergic reactions. The key players in T helper (Th) 2-type immunity are CD4^+^ Th2 cells and involve the cytokines interleukin (IL-)4, IL-5, IL-9, IL-10, and IL-13 and immunoglobulin (Ig)E. CD4^+^ Th2 cells also express some of the cytokines mentioned above as well as the chemokine ligand CCL11 and the chemokine receptor CCR3 \[[@B1]--[@B3]\]. These factors lead to recruitment and infiltration of eosinophils, basophils and mast cells, and expansion of alternatively activated macrophages \[[@B4]\]. Notably, Th2-type immune responses are composed of three major features: inflammation, wound repair, and, most importantly, resistance to helminths.

Parasites have developed various strategies to modulate the immune system and ultimately suppress host protective Th2-type immune responses for example, by induction of innate and adaptive regulatory cells, anti-inflammatory cytokines and specific inhibitory antibody isotypes (reviewed by Anthony et al. \[[@B2]\]).

Hence, helminth parasites are master regulators of immune responses in order to ensure life-long persistence in the host. One strategy of immune regulation that has evolved is the secretion of a wide range of immunoregulatory molecules, which are able to target various host cells and alter them to induce a highly directed host response known as a "modified Th2-type response." This response is designed to limit a possibly detrimental Th2 immune response, thus restraining the extreme symptoms that are often observed in allergy or in aspects of helminth diseases such as fibrosis in *Schistosoma mansoni*\[[@B3]\]. In immunological terms, the modified Th2 response is defined by the development of specific antibody isotypes, including induction of IgG4 accompanied by a decrease in IgE, as well as IL-4 and IL-5, while IL-10 levels from different regulatory cell sources increase \[[@B5]\]. These mechanisms can lead to attenuation of pathology and clinical symptoms, tolerance, and ultimately persistence of the worm, which is associated with a hyporesponsive immune system. Asymptomatic infection assures long-term survival of the parasite within the host and therefore sustains parasite feeding, completion of the life cycle, and successful reproduction \[[@B3], [@B5]\].

Many studies of animal and human helminth infections have shown their potential for downregulating the immune system. Moreover, relevant epidemiological studies have observed that helminth-infected populations exhibit lower levels of immunopathological diseases such as Th1-related autoimmune diseases or abberrant Th2-related diseases for example, asthma or allergic rhinitis. These observations indicate an inverse global distribution of allergy/autoimmune diseases and helminth infections, the first being an expanding problem of developed and industrialized countries, while the latter being a feature in developing countries \[[@B6]--[@B9]\]. Such findings support the hypothesis that the immune system has coevolved to operate in the presence of immunomodulatory helminth infections, while in the absence of exposure to helminths, the immunoregulatory components that would normally prevent allergy and autoimmune disease become weakened \[[@B5], [@B10]\].

Here, we focus on recent advances in cellular mechanisms that are employed and modulated during helminth infections as well as on reports from field research and studies on animal models. These studies have identified helminths and helminth-derived products that play a role either in induction of Th2 responses and immune modulation in parasitic infections (reviewed in [Table 1](#tab1){ref-type="table"}) or in downregulation of bystander Th2-type immunopathologies like allergic asthma, allergic inflammation and airway hyperreactivity, food allergy, eczema, atopic dermatitis (Th1/Th2), or anaphylaxis (reviewed in [Table 2](#tab2){ref-type="table"}).

2. Epidemiological Evidence of Helminth-Induced Immunoregulation {#sec2}
================================================================

2.1. Immunoregulation during Helminth Infection in Humans {#sec2.1}
---------------------------------------------------------

It has long been known that helminths induce a specific immune phenotype in the majority of persons that allows for establishment of infection while simultaneously preventing or reducing signs of disease in the host \[[@B11]\]. Antigen-specific cellular hyporesponsiveness was described for filarial infections more than 30 years ago by Ottesen et al. studying a population in the Cook Islands endemic for lymphatic filariasis. In this study lymphocytes from adults infected with the filarial species *Wuchereria bancrofti* showed significantly lower levels of proliferation in response to filarial antigen compared with endemic controls who were negative for all signs of infection or disease but constantly exposed to infection and, therefore, putatively consistently exposed to the antigens \[[@B12]\]. Later, another study from the same group made the distinction between microfilariae (mf) positive asymptomatically infected persons and mf negative patients showing clinical symptoms of filariasis (e.g., elephantiasis or hydrocoele) \[[@B13]\]. The resulting data suggested that the outcome of disease depends on the host response together with a mechanism of immune modulation induced by the parasite (reviewed by Ottesen \[[@B14]\]). Epidemiological studies of helminth-infected persons recognise distinct clinical outcomes that depend on immune regulation induced by the parasite in conjunction with the genetic background of the host (reviewed by Maizels and Yazdanbakhsh \[[@B3]\]). Resistant individuals are constantly exposed to the parasite but show no signs of infection or disease; this group develops an appropriate response, defined by equal proportions of Th1, Th2, and T regulatory (Treg) cells with a balance of IgG4 and IgE levels. A second group develops a hyporesponsive phenotype characterised by asymptomatic infection, which tolerates the presence of fecund adult worms. This group has high levels of regulatory cells and IL-10, leading to a modified Th2 response. Finally, a small proportion of patients develops a hyperresponsive phenotype (characterised by an immunopathological response) \[[@B3], [@B11], [@B14]\]. In *S. mansoni*, *W. bancrofti*, and *Brugia malayi* infections, the main pathological response is a result of overreactive T cell responses that cause inflammation and injure the host. This group exhibits increased IgE responses, and the Treg compartment is greatly diminished. In *W. bancrofti* and *B. malayi* infections, this can result in elephantiasis, whereby the lymphatic tissue becomes dilated and hypertrophic. Parasite death leads to the release of antigenic material that causes lymphatic obstruction in the vessels and chronic inflammation \[[@B14]\]. A second, rare result of these infections is tropical pulmonary eosinophilia characterised by chronic lung obstruction, peripheral blood eosinophilia, and extremely elevated levels of IgE, greater than in elephantiasis \[[@B15]\]. In *Onchocerca volvulus* infection the rare chronic hyperreactive form, known as Sowda, is also defined by high levels of IgE \[[@B16]\]. This is accompanied by strong Th2 responses, including IL-4, IL-5, and IL-13. Thus a fine balance of different aspects of immunity is required to develop a response beneficial to the host.

Therefore, immune modulation acts in favour of persistent infection and continuous transmission while simultaneously enabling the host to tolerate infection by diminishing clinical symptoms. Coinfection studies of helminths with other diseases provide supporting evidence that helminths have great ability to modulate immune responses, some aspects of which may then affect bystander infections. In fact, protective inflammatory immune responses that typically develop in bacterial or intracellular parasitic infections can be downregulated when a coinfecting helminth is present, resulting in increased susceptibility in the host to the former infection. For example, individuals coinfected with latent tuberculosis (TB) and *W. bancrofti* showed lower levels of TB-protective proinflammatory cytokines in vitro than TB patients without filarial infection. This effect was reversed after treatment with microfilaricidal drugs \[[@B17]\]. Research focusing on individuals coinfected with multiple filarial species and *Plasmodium falciparum* demonstrated a modulation of the antimalarial immune response by helminths that increased anti-inflammatory responses \[[@B18]\]. After stimulation with malaria antigen, filarial-infected individuals demonstrated significantly lower levels of interferon (IFN)-*γ*, tumour necrosis factor (TNF)-*α* and IL-17A, and higher levels of IL-10 from CD4^+^ T cells compared with filarial-uninfected individuals. Similarly, a study examining the effect of helminth infections on responses to oral cholera vaccine demonstrated that *Ascaris lumbricoides* infection was associated with lower cholera antigen-specific IL-2 cytokine responses \[[@B19]\]. These epidemiological studies demonstrate the ability of helminths to modulate immune responses to themselves as well as to concurring and unrelated infections.

2.2. Inverse Correlation between Helminth Infections and Allergic Reactions {#sec2.2}
---------------------------------------------------------------------------

Eradication of helminth infections in industrialised countries in the past 30 years has had a great impact on the prevalence of diseases associated with inappropriate immune responses. The observed increase in the appearance of allergy-related diseases might be a result of this and altered hygienic measures in everyday life. One possible explanation is the hygiene hypothesis \[[@B20], [@B21]\], which includes a number of factors like improved public health, use of antibiotics and vaccines that in consequence reduce the occurrence of viral, bacterial or helminth infections early in life, contributing to higher numbers of individuals with allergic, and/or autoimmune disorders.

There are numerous cohort studies determining allergic disease status and immune responses to parasite-specific antigens or environmental allergens of helminth-infected individuals in parasite-endemic areas (reviewed by others \[[@B6], [@B8]\]). However, when interpreting this data it is important to take into consideration the time of first infection, duration and intensity of infection, helminth species, as well as host genetic and environmental factors.

Infections with trematodes, whipworms and hookworms were described to be negatively correlated with the allergen skin prick test \[[@B22]\]. Results from a study of Gabonese school children tested for skin reaction to house dust mites (HDMs) and other allergens, for *Schistosoma* eggs in urine and microfilariae of *Loa loa*and *Mansonella perstans* in blood, showed lower prevalence of a positive skin test to HDMs in children with urinary schistosomiasis. Moreover, schistosome antigen-specific concentrations of IL-10 were significantly higher in infected children and concentrations of IL-10 were negatively associated with a positive skin test result \[[@B23]\].

Several population studies done in endemic areas of *Schistosoma* infections in Brazil \[[@B24], [@B25]\] and of *Ascaris*, *Trichuris*, and *Ancylostoma*in Ecuador \[[@B26]\] revealed a strong inverse association between helminth infections and immediate skin test reactivity to common environmental aeroallergens. Araujo et al. \[[@B24]\] and Cooper et al. \[[@B26]\] reported a negative association between very high levels of IgE antibodies and allergen skin test reactivity. It is possible that anti-helminth-IgE competes for the same high-affinity IgE receptors targeted by allergen-specific IgE \[[@B24]\]. Although other studies from Africa reported on a reverse association between hookworm infections and sensitization to HDM *Dermatophagoides pteronissinus* (Der p 1), they did not show a significant association between skin test sensitivity to HDMs, allergen-specific IgEs and between total serum IgE levels and helminth-specific IgEs \[[@B27], [@B28]\].

The contribution of helminth infections to the inverse correlation with allergy-related diseases was demonstrated in studies with anthelminthic treatment. Results from a randomized, controlled trial on the effect of repeated treatment with anthelminthics on a population of Gabonese school children showed a significant increase in the rate of developing skin sensitivity to HDMs. This was in part mediated by reductions of *Ascaris* and/or *Trichuris* infections, directly pointing to the importance of a presence of live worms to suppress allergic responses during infection and also preventing allergy later in life \[[@B29]\]. Lynch et al. also reported an effect of anthelminthic treatment on the allergic reactivity of children in the tropics in Venezuela. The authors showed that the effective elimination of intestinal helminth infection resulted in significantly decreased total serum IgE levels. However, immediate-hypersensitivity skin test reactivity and serum levels of specific IgE antibody against common allergens were significantly increased in treated children \[[@B30]\]. Also other studies reported that anthelminthic treatments increase allergen skin reactivity to environmental allergens \[[@B31], [@B32]\]. Rodrigues et al. reported that Brazilian children with heavy infection in early childhood with *Trichuris trichiura* had a lower prevalence of allergen skin test reactivity to a wide spectrum of common environmental allergens (HDMs, *Blomia tropicalis*, fungi, animal, and cockroach allergens) later in childhood, even when the helminth infection was no longer present \[[@B33]\]. Additionally, a population study in Taiwan showed that schoolchildren bearing pinworm *Enterobius* were diagnosed with lower prevalence of asthma and allergic rhinitis; moreover, these children had reported an infection of pinworms early on in life \[[@B34]\]. Thus, early exposures and infections with helminths may have a protective effect and suppress allergic inflammation later during life.

Additionally, host genetic factors may play a role in prevalence of helminth infections and allergies. Notably variants of genes involved in Th2 immune responses like *IL13* or *STAT6* were associated with increased risk of asthma and allergy \[[@B35]--[@B38]\]. Studies among African-Americans shed a light on the limited understanding we have on asthma genetics. Polymorphisms in candidate genes associated with asthma showed higher frequency among certain ethnic backgrounds that developed strong Th2 immune responses \[[@B6], [@B39], [@B40]\]. Thus, genes, which in the evolution of the immune system were initially responsible for induction of Th2-type immune responses and for parasite expulsion, now cause problems with allergy-related diseases when living in "sterile" and modern societies.

2.3. Helminth Infections that Promote Allergic Reactions {#sec2.3}
--------------------------------------------------------

In contrast to population studies reporting a negative correlation between allergy and helminth infections as discussed above, various studies from South America, Europe, and Asia on *A. lumbricoides* infections and allergy reported increased rather than decreased prevalence of asthma \[[@B41]--[@B43]\]. For example, two cross-sectional surveys among schoolchildren in former East Germany revealed that children with low doses of helminthic antigens (low worm burden) but *Ascaris*-IgE seropositivity had higher levels of total IgE and higher prevalence of allergic rhinitis and asthma to inhalant allergens \[[@B42]\]. It was proposed that heavy parasitic infections might generate immune suppressive mechanisms, whereas mild worm exposure and low-level contact with helminths may enhance reactivity to environmental allergens or even potentiate the Th2 immune response that in some cases may promote allergic inflammation. As *Ascaris*infection has been well-documented as a risk factor for asthma (described elsewhere \[[@B44]--[@B47]\]), there are two main hypotheses why *Ascaris*promotes allergic reactions. The first relates to the specific pulmonary phase in the *Ascaris* life cycle that causes inflammation and eosinophilia, which results in IgE-mediated asthma with high total- and specific-IgE titres against larvae and adult worms \[[@B48]\]. The second hypothesis of increased allergy in*Ascaris*infection is explained by cross-reactivity of *Ascaris*-specific molecules with environmental allergens like HDMs or the storage mites *B. tropicalis*that induce allergen-specific IgEs leading to strong Th2-type responses and therefore contributing to overall pathogenesis \[[@B49]\]. Moreover, *Ascaris*-tropomyosin, a pan allergen, induced wheal and flare in skin prick tests and histamine release from basophils of asthmatics and nonasthmatics. These results suggest that *Ascaris*-tropomyosin in some allergic individuals potentiates the pathogenesis of asthma and other allergic diseases \[[@B50]--[@B52]\].

Interestingly, the promotion of atopy can also be observed in parasitic infections where the human is not the definitive host and, therefore, chronic infection is not established, for example, *Toxocara* spp. \[[@B22], [@B53]\]. In addition, the nematode *Anisakis simplex*, regularly infecting marine mammals as definitive hosts but accidentally also leading to gastrointestinal (GI) infections in humans, who ingest raw fish, was described to cause allergic reactions. Allergy to *A. simplex*is being recognised as an occupational disease with a wide spectrum of allergic reactions (rhinitis, asthma urticaria, allergic contact dermatitis, and anaphylactic shock) \[[@B54]--[@B56]\]. As both parasites cause accidental and infrequent infections, in case of infection the immune system may be exposed to Th2-inducing events rather than to immunomodulatory mechanisms that occur in chronic infections. These may contribute to the immune pathology and lead to allergic reactions.

It is important to keep in mind that variations in epidemiological studies may have many confounding factors like types of parasitic infections, intensity and timing of the infection, other coinfections, first exposure to allergen as compared to parasitic infection, types of allergens, nutritional status of the patients, medication received, and genetic background.

3. Host Cells Targeted by Helminth Infections {#sec3}
=============================================

Current research has focused particularly on identifying the cells targeted by parasitic immune modulation, and the exact helminth-derived molecules responsible for this. Immune modulation by the parasite occurs through production of specific parasite-derived molecules that target mammalian host immune cells and signaling pathways. During infection this is strictly dependent on live parasites as shown by the recovery of cellular hyporesponsiveness in patients treated with anthelminthic chemotherapy \[[@B57]\]. In addition, a study by Da\'dara and Harn demonstrated that killing of schistosome parasites could reinstate immune responses to a bystander vaccine targeting human immunodeficiency virus-1, which were greatly diminished in the presence of the parasite \[[@B58]\]. Similarly, another study demonstrated that prior elimination of intestinal helminths in patients vaccinated with bacille Calmette-Guerin resulted in greater protective responses to the vaccine compared with patients who did not receive anthelminthic chemotherapy \[[@B59]\]. During active infection, live worms are thus normally essential to ensure constant release of immunomodulatory molecules. Both GI and tissue-dwelling helminths can establish long-term chronic infections and have many immunomodulatory molecules in common, which, despite the different anatomical locations target similar host cells employing comparable regulatory mechanisms. Thus, experimental models together with human studies have helped to elucidate the mechanisms and cell targets underlying parasite-induced immune modulation. In this section, we discuss some of the most common and relevant examples.

3.1. Dendritic Cells {#sec3.1}
--------------------

As professional antigen presenting cells (APCs) required in priming the adaptive immune response, dendritic cells (DCs) are an essential driving force of Th2 induction in helminth infections and in allergy-related diseases. The field of research on DCs targeted by parasite-induced immune modulation is as vast as that on macrophages, and there is definitive evidence of a specific DC phenotype that develops in helminth infection, demonstrating modulation by the parasite to deviate host inflammatory responses. Several groups could show that in helminth infection, DCs mature only selectively or show impaired functions in terms of TLR responsiveness \[[@B60]--[@B63]\]. As DCs are the main messenger cells to communicate with T cells and initiate an immune response, interference with their functions represents a key mechanism for helminths to induce an environment conducive to their survival \[[@B64]\].

The downregulation of proinflammatory cytokines appears to be a frequent feature in helminth-mediated modulation of the Th2-type response \[[@B65]\]. Murine DCs stimulated with lipids from *S. mansoni* eggs matured to induce specifically Tregs that produced IL-10, reducing Th1 responses whilst producing a modulated Th2 response \[[@B66]\]. However, as reviewed by Carvalho et al. \[[@B65]\] DCs that have been previously exposed to helminth products can also effectively prime Th2 cells. *S. mansoni* soluble egg antigen (SEA) is a particularly strong inducer of Th2 responses, and importantly the glycoprotein omega-1 was identified as the main Th2-inducing component in SEA \[[@B67]\]. Human DCs exposed to *B. malayi* mf showed higher levels of apoptosis and decreased production of IL-12 and IL-10 \[[@B68]\]. In fact when human monocytes that were being differentiated to DCs in vitro were stimulated with *B. malayi* mf antigen, they produced significantly decreased levels of IL-12p40, IL-12p70, and IL-10 in response to bacterial adjuvant \[[@B62]\]. Massacand et al. also demonstrated how DCs exposed to excretory-secretory (ES) products from both *Nippostrongylus brasiliensis*and *Heligmosomoides polygyrus* had reduced expression of the proinflammatory cytokine IL-12/23p40 \[[@B69]\]. Similarly, Balic et al. reported that bone-marrow-derived DCs exposed to *N. brasiliensis* ES (NES) products actively matured and could induce a Th2 response when transferred into naïve mice \[[@B60]\]. High levels of IL-4, IL-5, and IL-10 were detected after reexposure to NES. In vitro, these DCs produced high levels of IL-6 and IL-12p40 but full production of IL-12p70 was blocked. Finally it was shown that murine lipopolysaccharide- (LPS-) or CpG-matured DCs exposed to ES products from *Taenia crassiceps* showed diminished responses to stimulation through TLRs 4 and 9. These DCs significantly decreased levels of proinflammatory cytokines, including IL-12p40 and IL-12p70, as well as TNF-*α* and IL-15. IL-10 was, however not affected in this study \[[@B70]\]. Thus, downregulation of proinflammatory cytokines seems to be a frequent mechanism in immune modulation by helminths.

Combined with suppression of proinflammatory cytokines, a key aspect in modulation of DCs is the downregulation of costimulatory molecules, leading to induction of a Th2 response \[[@B65]\]. Dowling et al. illustrated that stimulation of murine bone-marrow-derived DCs with *A. lumbricoides* pseudocoelomic body fluid (ABF) influenced DC maturation by inducing expression of IL-6, IL-12p40, and macrophage inflammatory protein 2. However, DC maturation was only partial as levels of costimulatory molecules CD80, CD86, CD40, OX40L, and major histocompatibility complex (MHC) class II were not affected. Furthermore, when DCs were cultured in the presence of ovalbumin (OVA) with ABF and then transferred into naïve mice, restimulation resulted in significantly increased levels of IL-4, IL-5, and IL-10 compared to DCs cultured without ABF \[[@B71]\]. Coculturing of ES products but not adult worm antigen from *H. polygyrus* with LPS-treated DCs induced a semimature phenotype with moderate expression of CD40, CD86, and MHC class II \[[@B61]\]. In fact when DCs were treated with ES and OVA and subsequently cultured with OVA-specific T cells, the T cells developed a regulatory phenotype, expressing CD25 and high levels of IL-10 \[[@B61]\]. Thus, targeted DCs could suppress both Th1 and Th2 responses. Furthermore, a novel subset of DCs expressing low levels of CD11c have also recently been identified in mice chronically infected with *H. polygyrus*\[[@B72]\]. In this infection setting, DCs acted as efficient APCs and induced high numbers of CD4^+^ T cells expressing Foxp3 but only low numbers of CD4^+^ effector T cells. This population of DCs was suggested to be one of the main target cells involved in inducing an immunoregulatory environment in *H. polygyrus* infection, allowing the establishment of chronic infection \[[@B72]\]. Nevertheless, DCs are clearly essential for efficient priming of the Th2 response, as depletion of CD11c^+^ cells during development of the adaptive CD4^+^ T cell response in *S. mansoni* infection drastically impaired the Th2 response \[[@B73]\].

3.2. Alternatively Activated Macrophages {#sec3.2}
----------------------------------------

Macrophages that are activated by the Th2-type cytokines IL-4 and IL-13 develop an alternatively activated phenotype and have a well-described role in helminth infections (reviewed by Hoerauf et al. \[[@B74]\]). Alternatively activated macrophages (AAMs) are recruited in large numbers to the sites of helminth infection where they can proliferate, as recently shown \[[@B4]\]. AAMs are characterised in mice by expression of specific markers, including arginase-1, resistin-like molecule (RELM)-*α* (also known as found in inflammatory zone, FIZZ1), Ym-1, Ym-2, acidic mammalian chitinase (AMCase), and mannose receptor C type (MRC)-1 \[[@B75]\]. AAMs are important in tissue homeostasis, downregulation of the adaptive immune system, acting as effector cells against parasites, and to reduce or heal any ensuing damage caused by infection \[[@B76]\]. In particular, AAM-derived arginase-1 is important for wound healing \[[@B77]\]. AAMs recruited during *B. malayi* infection have been demonstrated to drive CD4^+^ Th2 responses, deviating the immune system from inducing a proinflammatory Th1 response that could be detrimental to parasite survival \[[@B78]\]. Monocytes from *B. malayi* asymptomatically infected patients have also been described to show an alternatively activated phenotype, expressing the AAM-specific markers arginase-1, MRC-1, resistin, and CCL18 as well as the downregulatory cytokines transforming growth factor (TGF)-*β* and IL-10 \[[@B79]\] (similar to what has been described for mouse AAMs \[[@B80]\]). However, translation of characterised markers into the human system in general should be done with caution, as reports indicate arginase-1 may not be a reliable marker for AAMs in humans as it is found in other cell types \[[@B81]\]. Furthermore, human monocytes do not express arginase-1 after stimulation with IL-4 and IL-13, unlike mouse macrophages (reviewed by Raes et al. \[[@B82]\]). This indicates that the translation from murine to human data can be difficult, and reliable markers for alternative activation in human monocytes should be further investigated.

The importance of AAMs is clear from numerous mouse models. Macrophages from *B. malayi* infected mice were shown to be fully capable of processing and presenting antigen and providing costimulation for T cells, however the resulting antigen-specific T cell population remained suboptimal with cell proliferation but not Th2 cell cytokine production being impaired \[[@B83]\]. These macrophages were IL-4-dependent and required direct contact with T cells to induce hyporesponsiveness \[[@B84]\]. In a mouse model of *S. mansoni* infection, arginase-expressing macrophages played an essential role in host protection by suppressing expression of the classical inflammatory cytokines IL-12 and IL-23 \[[@B85]\]. Removal of these cells resulted in an accumulation of parasite eggs in the intestines and intestinal haemorrhage, thus preventing the eggs from being excreted. Slightly different effector functions of AAMs come into play in GI helminth infections. Large numbers of AAMs were shown to accumulate in *N. brasiliensis* infection in the gut, characterised by expression of arginase-1, RELM-*α* and Ym-1, in an IL-4- and IL-13-dependent manner \[[@B86]\]. Macrophage depletion resulted in impaired worm expulsion from the small intestine and prevented smooth muscle hypercontractility.

RELM-*α* in particular has a clear immunomodulatory role during infection. RELM-*α* was shown to be essential in regulating lung inflammation, granuloma size and fibrosis in mice challenged with *S. mansoni* eggs \[[@B87]\]. Additionally, RELM-*α* deficient mice could not control Th2 cell differentiation or cytokine production. Moreover, Pesce et al. illustrated that challenge of RELM-*α* deficient mice with *S. mansoni*eggs resulted in elevated eosinophil levels and IgE titres. In the same study RELM-*α* deficient mice challenged with *N. brasiliensis* infection produced increased Th2 responses, manifested by elevated lung pathology and expulsion of adult worms. Importantly, addition of exogenous RELM-*α* reversed the pathological Th2 responses in this infection \[[@B88]\]. This represents RELM-*α* as a key host-derived molecule induced by helminth infection to allow prolonged parasite survival. These studies point at a host protective role for AAMs in specific tissue dwelling and GI helminth infections.

3.3. Regulatory T Cells {#sec3.3}
-----------------------

Among the cell types targeted during helminth infections, CD4^+^ Tregs are particularly implicated in controlling innate and adaptive immunity. Natural CD4^+^ Tregs develop in the thymus and express the transcription factor Foxp3, the IL-2 receptor *α* chain (CD25), CTLA-4, and a range of immunosuppressive proteins including IL-10 and TGF-*β* \[[@B89]\]. Additionally, other adaptive CD25^+^ Treg populations exist in the periphery that develop from nonregulatory T cell subsets, with their expression of IL-10 and TGF-*β* distinguishing them from activated CD4^+^CD25^+^ nonregulatory T cells. Tregs are important in reducing pathology in the host via suppression of both Th1 and Th2 responses, thus preventing disease symptoms as demonstrated by evidence of Treg involvement in both Th2-mediated allergies and Th1-mediated autoimmunity (reviewed by Else \[[@B90]\]). In a murine model of schistosomiasis CD4^+^CD25^+^ T cells expressing high quantities of IL-10 were shown to play a significant role in reducing immunopathology, especially in the chronic stage of infection \[[@B91]\]. McKee and Pearce illustrated that in *S. mansoni*-infected mice CD4^+^CD25^+^Foxp3^+^ cells produced significant levels of IL-10 that were required to prevent DC-derived IL-12, thereby suppressing Th1 responses \[[@B92]\]. In fact, isolated schistosome eggs were demonstrated to be capable of modulating Th2 responses, without the need for the former life cycle stages that develop during infection. Schistosome eggs injected into mice were shown to induce a population of Foxp3^+^ cells that expanded to control the CD4^+^ T cell response, preventing inflammatory Th1 responses while modulating Th2 responses to prevent Th2-mediated immunopathology \[[@B93]\]. Both natural and adaptive Tregs have been described in filarial-infected persons, with the adaptive Treg population producing high levels of IL-10 \[[@B94]\]. Our group has shown that in *H. polygyrus*infection, Foxp3^+^ Tregs are a requirement for limiting immunopathology and represent a potential source of IL-10 \[[@B95], [@B96]\]. Thus, while Treg depletion did not affect worm burdens, the Th2 response was greatly accelerated and augmented, with high levels of IL-4 and IL-13 being produced. The uncontrolled Th2 response led to increased immunopathology in the intestine, demonstrating that Tregs were essential in regulating this response \[[@B96]\]. Foxp3^+^ Tregs were also induced after stimulation with *H. polygyrus* ES products, reducing proliferation of effector cells by activating the TGF-*β* signaling pathway \[[@B97]\]. During infection, Tregs may therefore be seen as important effector cells required to prevent or reduce pathology in the host by modulating the ensuing Th2 response, thereby simultaneously allowing establishment of chronic infection.

3.4. B Cells {#sec3.4}
------------

Host protection as well as regulation by antibodies and B cells is being recognised as an essential component in Th2 responses in helminth infections \[[@B98]\]. In *S. mansoni*-infected mice, where the dominant isotypes are IgG1 and IgE \[[@B98]\], blockade of B cell production resulted in high levels of the proinflammatory cytokines IFN-*γ* and IL-12 but low levels of the Th2 cytokines IL-4 and IL-10 in acute infection \[[@B99]\]. Moreover mice deficient in B cells could not downregulate granuloma formation in the chronic stage of infection, and this mechanism was mediated by Fc*γ*R, indicating a role for antibodies in down modulation of pathology \[[@B100]\]. In fact, antibody isotypes are demonstrated to have an important role in determining the outcome of helminth infection in the host. The cytokines IL-4 and IL-13 act on B cells to induce both IgG1 and IgE in mice and IgG4 and IgE in humans. High levels of IgG4 but low levels of IgE are found in the blood of hyporesponsive, asymptomatic persons infected with *B. malayi*, *W. bancrofti,* and *O. volvulus* \[[@B16], [@B101]\]. IgG4 correlates with high levels of IL-10 and the presence of adult worms in hyporesponsive persons. In Bancroftian filariasis, high levels of IgG4 \[[@B102]\] but low levels of IgE \[[@B103]\] were found in mf positive individuals compared to patients with clinical disease (elephantiasis or tropical pulmonary eosinophilia). IgE is known to activate degranulation of mast cells (MCs), basophils and eosinophils and induce antibody-dependent cell-mediated cytoxicity (ADCC) \[[@B98], [@B104]\]. IgG1 in mice and IgG4 in humans compete with IgE for binding sites and therefore may inhibit such processes. In fact, IgG4 has downstream suppressive effects, such as inhibiting complement activation \[[@B105]\]. Thus, inhibitory IgG4 may prevent immunopathological responses in helminth asymptomatically infected individuals and can simultaneously provide an indication of the clinical outcome in infected persons.

Regulatory B cells have been first described in autoimmune diseases, where the main mediator of suppression is IL-10 \[[@B98]\]. Helminth infections can also induce specific B cell phenotypes with regulatory properties as shown in infection with *S. mansoni* and *H. polygyrus* \[[@B106]\]. In *S. mansoni* infection, a particular subset of B cells has been described that are CD1d^high^ and express high levels of IL-10 (defined as CD19^+^IL-10^+^CD1d^high^CD5^+^CD21^high^CD23^+^IgD^+^IgM^high^cells). Transfer of these cells into OVA-sensitized mice reduced OVA-induced allergic airway inflammation via induction of Foxp3^+^ Tregs; the effect was TGF-*β* independent as showed in anti-TGF-*β* mAb treatment experiments \[[@B107]\]. Furthermore, another group demonstrated that transfer of IL-10-producing B cells from IL-4 deficient mice infected with *S. mansoni* provided complete resistance to experimentally induced anaphylaxis when applied to naïve mice. Thus, absence of IL-4 was essential to prevent exacerbation of this allergic response \[[@B108]\]. In another study, the same group proved that the protective response of *S. mansoni* infection was entirely dependent on B cells as depletion of IgM^+^ B cells resulted in mice becoming completely susceptible to anaphylaxis \[[@B109]\]. Interestingly, adoptive transfer of a population of CD19^+^CD23^high^ B cells from *H. polygyrus*-infected mice could reduce the effects of allergic airway inflammation of OVA-sensitized mice, however, in an IL-10 independent manner. These mesenteric lymph node B cells reduced secretion of IL-5 and infiltration of eosinophils into the airways, suppressing allergen-induced pathology \[[@B110]\]. Thus, B cells from helminth infections exhibit regulatory capacity in unrelated diseases and are of therapeutic interest in allergies, therefore their phenotype and functional aspects should be further investigated.

4. Immunomodulatory Effects of Helminth-Derived Molecules and Their Role in Modulation of Allergy-Related Diseases {#sec4}
==================================================================================================================

There are numerous studies examining the effects of different helminth infections (e.g., *S. mansoni* \[[@B108]--[@B111]\], *H. polygyrus* \[[@B113], [@B114], [@B112]\], *N. brasiliensis* \[[@B115]\], *Trichinella spiralis* \[[@B116]\], and *Litomosoides sigmodontis* \[[@B117]\]) on allergy-related diseases in experimental animal models, where helminths show the capacity to suppress abberrant Th2 immune responses. In addition, ES products either from *H. polygyrus* \[[@B97]\] or *N. brasiliensis* \[[@B118]\] were described to have similar beneficial immunoregulatory effects. Furthermore, helminths act through various cell types and can interfere with allergy symptoms in animal models via distinct mechanisms including Tregs \[[@B119], [@B97], [@B117]\], B cells \[[@B108], [@B110], [@B107]\], and induction of regulatory cytokines like IL-10 \[[@B113], [@B114], [@B115], [@B116]\] or TGF-*β* \[[@B116], [@B117], [@B107]\], as discussed in the previous section and reviewed in [Table 2](#tab2){ref-type="table"}.

These and other studies led to the discovery of specific immunomodulatory helminth-derived molecules and products that induce a microenvironment beneficial to the parasite, while at the same time preventing immune-related pathology associated with vigorous Th2 responses ([Figure 1](#fig1){ref-type="fig"}). However, as mentioned earlier, persistence of the parasite is not obligatory to reduce allergic symptoms in later life \[[@B33]\]. Moreover, these functionally and structurally diverse molecules are expressed throughout the parasite life cycle and interact directly with host cells. A summary of helminth-derived immunomodulatory molecules and products is given in [Table 1](#tab1){ref-type="table"}. We focus here on molecules that are relevant for human disease, established animal models of host-parasite interactions, and defined molecules that downregulate unrelated Th2 inflammation.

4.1. Homologues of Mammalian Cytokines and Chemokines {#sec4.1}
-----------------------------------------------------

The existence of parasite-derived homologues of host mammalian anti-inflammatory cytokines reveals an apparent evolutionary struggle between the parasite and the host, whereby the parasite has evolved mechanisms to establish chronic infection. For example, two TGF-*β* homologues found in *Brugia* species, *Bm-tgh-1* and *Bm-tgh-2*, have been well characterised, the second of which is thought to have an immunomodulatory role. TGH-2 is secreted by adult worms and in its recombinant form was shown to bind the human TGF-*β* receptor, thus potentially influencing Treg development \[[@B121], [@B120]\]. *S. mansoni* male worms express a member of the TGF-*β* receptor family known as SmRK-1 \[[@B122]\] for which mammalian TGF-*β* may be a ligand involved in worm development \[[@B123]\]. *H. polygyrus* ES contains remarkable TGF-*β*-like activity, inducing Foxp3 expression in naïve T cells and modulating immune functions, thereby maintaining worm burdens to induce chronic infection \[[@B97]\].

The beneficial role of homologues of mammalian chemokines such as macrophage migration inhibitory factor (MIF) is less apparent. MIF homologues have been described in multiple helminth species (reviewed elsewhere \[[@B124], [@B125]\]). Mammalian MIF has numerous functions, in particular as a proinflammatory cytokine \[[@B125]\]. Helminth MIF has direct chemotactic effects on human monocytes but appears to be associated with anti-inflammatory, modified Th2-type responses \[[@B126]\]. In a murine model of asthma, a recombinant MIF-like protein from *A. simplex* (*As*-MIF) was described to have a protective effect and to suppress the Th2-type response, reduce production of IL-4, -5 and -13 in the bronchoalveolar lavage fluid (BAL), inhibit eosinophilia, goblet cell hyperplasia, and ameliorate lung hyperreactivity. The effect of *As*-MIF was possibly mediated by IL-10 and TGF-*β* production in the BAL as well as via Treg induction in the lungs of *As*-MIF-treated animals when compared to asthmatic controls \[[@B127]\].

Another helminth-derived molecule with structural similarities to mammalian chemokines is *Ancylostoma*-secreted protein-2 (*Na*-ASP-2) secreted by the infective larvae of *Necator americanus* hookworm. Recombinant *Na*-ASP-2 was shown to recruit high numbers of neutrophils when injected into an air pouch (a sterile inflammatory setting) in mice. The influx of neutrophils was suggested to create permeability in host vessels, thus facilitating larval migration \[[@B128]\]. Hence, cytokine homologues seem to be exploited by the parasite for efficient immune evasion; however more work is needed to assess which of those molecules participate in suppression of unrelated inflammation.

4.2. Protease Inhibitors {#sec4.2}
------------------------

The cystatins and serpins are the best-characterised protease inhibitors of helminths that have immunomodulatory potential. Mammalian cysteine proteases are essential for efficient processing and presentation of antigen on MHC class II to induce an appropriate adaptive T cell response. Mammalian cystatins play a vital role in regulating these pathways; however, helminth cystatins from *Acanthocheilonema viteae*, *B. malayi*,*N. brasiliensis*, and *O. volvulus* have been shown to interfere with this process to dampen antigen-dependent immune reactions (reviewed by Klotz et al. \[[@B129]\]). *Bm*-CPI-2, a cystatin from *B. malayi*, was illustrated to interfere with antigen processing, which led to a reduced number of epitopes presented to T cells in vitro \[[@B130]\]. Studies from our own group have demonstrated that onchocystatin (rOv17) from *O. Volvulus* reduced antigen-driven proliferation of peripheral blood mononuclear cells in a monocyte-dependent manner \[[@B131]\]. Recombinant AvCystatin (rAv17) from *A. viteae* has potent immunomodulatory roles illustrated by its ability to reduce antigen-specific and unspecific T cell responses \[[@B132]\]. AvCystatin is recognised by macrophages and upon uptake induces phosphorylation of the mitogen-activated protein kinase signaling pathways ERK1/2 and p38 in macrophages. This led to tyrosine kinase-dependent IL-10 production in macrophages \[[@B132], [@B133]\]. Furthermore, we could show in an OVA-induced airway hyperreactivity mouse model that AvCystatin-treated asthmatic mice exhibited amelioration of the disease. AvCystatin administered intraperitoneally (i.p.) during the sensitization phase as well as before challenge with OVA, suppressed recruitment of eosinophils into the lungs, OVA-specific and total IgE levels, and reduced allergen-specific IL-4 production. IL-10 is a key element in AvCystatin-induced immunomodulation, as blocking of IL-10 with an anti-IL-10R mAb reversed the beneficial effect on cell recruitment and production of IgE \[[@B134]\]. Moreover, depletion of macrophages with clodronate liposomes before airway allergen challenge diminished the antiallergic effect of AvCystatin \[[@B134]\].

The rodent filarial species *L. sigmodontis* secretes a cystatin at various stages of the life cycle, which after injection via microosmotic pumps into the peritoneal cavity of *L. sigmodontis*-infected mice greatly decreased nitric oxide production and proliferation of antigen-specific spleen cells \[[@B135]\].

Similarly, recombinant cystatin from the ES product of the GI nematode *N. brasiliensis*(named nippocystatin, NbCys) was shown to inhibit cathepsins L and B, and suppressed antigen processing by APCs \[[@B136]\]. Furthermore, OVA-sensitized and NbCys-treated mice showed decreased OVA-specific spleen cell proliferation, reduced OVA-specific IgE levels and cytokine production due to inhibition of cathepsin B and L-dependent antigen processing \[[@B137]\].

Similar to cystatins, serpins (serine protease inhibitors) have important roles in mammalian biological processes including regulation of complement activation, inflammatory pathways, and cell interactions. *Bm*-SPN-2 is a serpin expressed by *B. malayi* microfilariae, which could inhibit proteases of human neutrophils, thereby interfering with and potentially circumventing the most abundant leukocyte to encounter mf in the bloodstream \[[@B138]\]. However, another study by Stanley and Stein contests the enzymatic activity of *Bm*-SPN-2 \[[@B139]\]. Thus, further studies should clarify the role of serpins as immunomodulatory molecules. Taken together, protease inhibitors such as cystatins are a class of molecules found in numerous helminths that have important immunomodulatory functions.

4.3. ES-62 {#sec4.3}
----------

A secreted 62 kDa glycoprotein from *A. viteae* known as ES-62 is one of the best-characterised helminth immunomodulators. ES-62 has been shown to exhibit a plethora of well-documented anti-inflammatory properties \[[@B140]\] and contains phosphorylcholine moieties, which are largely responsible for immunomodulation (reviewed by Harnett et al. \[[@B141]\]). OVA-specific CD4^+^ T cells exhibited lower levels of proliferation and IL-2 production after challenge with ES-62, as well as inhibition of IL-4 and IL-13 \[[@B142]\]. It was also shown that ES-62 acts on macrophages to inhibit production of IL-12 if the cells were subsequently exposed to LPS and IFN-*γ* \[[@B143], [@B144]\]. ES-62 could also be shown to act on bone-marrow-derived precursors of DCs to inhibit a proinflammatory response induced by LPS \[[@B145]\] and B cells by modulating T and B cell interactions \[[@B146]\]. ES-62 is also active against Fc*ε*RI-mediated MC responses in vitro. It directly inhibited Fc*ε*RI-induced release of allergy mediators from human MCs by selectively blocking key signal transduction events. ES-62 also interfered with MCs in vivo in a mouse model of immediate-type hypersensitivity to oxazolone, thereby diminishing ear swelling and MC-dependent hypersensitivity, as well as ex vivo MC degranulation in mice that were previously injected with the molecule. Moreover, ES-62 ameliorated OVA-induced murine airway inflammation, airway hyperresponsiveness, lung pathology, and eosinophilia by suppression of MC function \[[@B147]\]. Thus, ES-62 is likely to be a key mediator of filarial-induced immunoregulation, and its properties might be used to dampen overwhelming unrelated inflammation in the future.

4.4. Schistosome-Derived Antigens {#sec4.4}
---------------------------------

Schistosome soluble egg antigen (SEA) and ES products released by the egg stage of the parasite contain potent Th2-inducing and immunomodulatory activity. SEA from *S. mansoni* was shown to be an extremely strong inducer of Th2 responses without the need for live infection or the addition of adjuvant \[[@B148]\]. Recently it was shown that omega-1, a hepatotoxic ribonuclease, is one of the key players in this response \[[@B67], [@B149]\]. Omega-1 is a glycoprotein, which was demonstrated to polarise human monocyte-derived and CD11c^+^ murine DCs in a direction supporting Th2 responses even in the presence of LPS. In fact, SEA depleted of omega-1 was not able to sufficiently induce a Th2 response in vitro \[[@B149]\]. However, the Th2-suppressive actions of schistosome-derived antigens clearly highlight the ability of this helminth to modulate host immune responses. ES- or omega-1-treated DCs display the typical modulated phenotype that is critical for induction of a Th2 response, including reduced expression of costimulatory molecules and a lowered efficiency in participating in DC-T cell conjugates \[[@B67]\]. In fact, this study demonstrated that omega-1 was shown to alter the morphology of DCs, possibly preventing T cell activation. IPSE/alpha-1 is another glycoprotein present in SEA and abundant in ES, which could induce IL-4 production from human basophils in an IgE-dependent but antigen-independent mechanism \[[@B150]\]. *S. mansoni* also expresses glycans that have been shown to exhibit immunomodulatory functions. Okano et al. demonstrated that glycan-containing SEA could induce high levels of IL-5, IgE production, and eosinophilia when administered intranasally into mice \[[@B148]\]. The same group was subsequently able to show that *S. mansoni* SEA contained the carbohydrate lacto-N-fucopentaose III (LNFPIII), which induced high levels of IL-4, IL-5, and IL-10 by nasal lymphocytes bypassing the need for an adjuvant \[[@B151]\]. DCs are also targeted by lyso-phosphatidylserine (Lyso-PS) present in SEA, to dampen the Th2 response. Lyso-PS was shown to act on DCs via the TLR2 pathway, endowing them with the ability to induce IL-10-producing Treg cells \[[@B66]\].

Whole SEA, as well as SEA-derived molecules, has been described to interfere with animal models of allergy-related diseases. Yang et al. used *S. japonicum* SEA to test its effect in experimentally induced asthma in mice. SEA increased IL-10 production and expression of Foxp3 on CD4^+^CD25^+^ T cells, both with immunosuppressive activity, while at the same time decreasing the expression of Th2 (IL-4 and IL-5) cytokines, suppressed antigen-induced airway inflammation, recruitment of inflammatory cells into the lungs, and development of asthma \[[@B152]\]. *S. mansoni* egg-secreted chemokine-binding protein (smCKBP) was reported to significantly diminish ear swelling of hapten-sensitized mice in a contact hypersensitivity model. Isolation of the inflammatory infiltrate from hapten-treated ears of smCKBP-treated mice showed reduction of neutrophilia when compared to cells isolated from the ears of control animals. Smith et al. showed that smCKBP has specific in vivo activity, suppressing immediate or local inflammation \[[@B153]\]. Additionally, three *S. mansoni* antigens Sm22.6 (soluble protein associated with the *S. mansoni* tegument), PIII (a multivalent antigen of *S. mansoni* adult worms), and Sm29 (a membrane bound glycoprotein on the *S. mansoni* adult worm tegument) were evaluated in the OVA-induced airway inflammation mouse model. All three antigens showed a beneficial immunomodulatory effect in this allergy model characterised by suppression of airway inflammation, reduced eosinophilia in the lungs, decreased OVA-specific IgE levels, and lower Th2-specific cytokine production in BAL when compared to asthmatic animals. Sm22.6 significantly induced higher levels of IL-10, while both Sm22.6 and PIII lead to increased expression of CD4^+^Foxp3^+^ T cells suggesting that Treg cells might be involved in the modulation of this aberrant Th2 inflammation \[[@B154]\].

4.5. Molecules of *Ascaris suum* {#sec4.5}
--------------------------------

Although *Ascaris*infections are described to support allergic inflammation ([Section 2.3](#sec2.3){ref-type="sec"}), products from *A. suum* have also been described to contain immunomodulatory activity, in particular the 200 kDa protein PAS-1. Administration of PAS-1 to mice that had been injected with LPS into sterile air pouches resulted in a significant decrease in neutrophil migration as well as suppressing proinflammatory cytokines IL-6, TNF-*α*, and IL-1*β* \[[@B155]\]. In particular, significant effects of PAS-1 have been demonstrated in allergy. Itami et al. \[[@B158]\] used a murine model of asthma induced by another *A. suum*-molecule, APAS-3 that promotes IgE production \[[@B156]\], to test the suppressive effect of PAS-1 \[[@B157]\]. In this experimental model of asthma induced by APAS-3, PAS-1-treated mice showed decreased eosinophil migration into the lungs, lower IL-4, IL-5, CCL11 and RANTES production in the BAL, as well as reduced airway hyperreactivity. Moreover, IL-10 production was considerably increased after PAS-1 treatment when compared to APAS-3-immunized controls. Thus, *A. suum* has allergenic components as well as suppressive products that downregulate allergic responses \[[@B158]\]. More recently, a study from the same group showed suppressive effect of PAS-1 also in OVA-induced airway inflammation. In line with previous findings, PAS-1 reduced eosinophilia, decreased production of Th2 associated cytokines in the BAL and OVA-specific IgE and IgG1 levels in serum. Moreover, the effect was observed in IL-12- but not in IL-10- and IFN-*γ*-deficient animals, thus IL-10 and IFN-*γ* played a role in the immunomodulatory effect of PAS-1 \[[@B159]\]. Furthermore, the authors reported that the immunomodulatory effect of PAS-1 was mediated by CD4^+^CD25^+^ and CD8^+^ T cells as shown by adoptive cell-transfer into OVA-sensitized and challenged mice. Recipients of PAS-1-primed CD4^+^CD25^+^ T cells had increased levels of IL-10/TGF-*β* whereas mice with transferred PAS-1-primed CD8^+^ T cells showed prominent IFN-*γ* production \[[@B160]\]. Those three cytokines were described to play important roles in the suppression of allergic diseases and reported to be strongly induced during successful allergen-specific immunotherapy in humans as reviewed by Holgate and Polosa \[[@B161]\].

5. Conclusion {#sec5}
=============

Helminths have had millions of years to evolve regulatory mechanisms that circumvent the mammalian immune response and allow for the longevity characteristically observed during infection. Thus, understanding of this coevolutionary nature is important in order to comprehend the immunomodulatory potential of helminth-derived molecules. This will better allow the development of therapeutical targets in symptomatic disease in helminth infections and help to break transmission of infection in endemic countries. Furthermore, the genetic basis underlying differences in responses of different individuals to helminth infections should be examined to develop a full understanding of these parasites, and current studies are beginning to address this. In particular, relevant experimental models for filarial disease are required to study both asymptomatic and pathological responses.

The connection between helminth infections and allergy is of particular interest. The epidemiological data reported in this paper together with experimental studies clearly support the view of the immunomodulatory potential of helminth-derived products to interfere with and even prevent aberrant allergic inflammation. These interactions are summarised in [Figure 1](#fig1){ref-type="fig"}.

Research should focus on studying the immunomodulatory effects of helminth-derived products on allergy and strive to develop new therapeutic strategies by identifying the mechanisms and pathways utilised by such molecules in mediating their immunomodulatory effects.
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![Regulatory and effector mechanisms of Th2-type responses. *Th2 immune response in helminth infection*: helminth infection induces a protective Th2 immune response. Professional antigen presenting cells such as dendritic cells (DCs) process helminth antigens and display them to CD4^+^ T cells that differentiate into polarised T helper 2 cells. Th2 cells produce cytokines such as IL-4, -5, and -13 that activate and attract macrophages, eosinophils, and other innate immune cells as well as B cells. IL-4 and -13 induce differentiation of antigen-specific B cells and production of large amounts of antibodies (characteristically IgE). Antibodies opsonise the helminths leading to killing via eosinophils or neutrophils, as well as macrophages by antibody-dependent cellular toxicity (ADCC). IgEs bind to Fc*ε*-receptors (Fc*ε*RI) on mast cells (MCs). Sensitized MCs secrete large amounts of histamine and other mediators and facilitate the attraction and accumulation of further immune cells, which result in larvae killing.*Regulatory mechanisms in helminth infection:* Helminths induce immunoregulation via modulation of immune cells leading to alternatively activated macrophages (AAMs), regulatory T cells (Treg), and B cells. AAMs in mice express among others arginase-1 (Arg 1), resistin-like molecule-*α* (RELM-*α*), Ym-1, Ym-2, IL-10, and TGF-*β* and contribute to wound healing. Treg produce IL-10 and transforming growth factor-*β* (TGF-*β*), whereas B cells can elicit regulatory mechanisms via IL-10. These cellular changes lead to modified Th2 immune responses and larvae survival as well as blocking of unrelated inflammation such as allergic immune responses.*Allergic inflammation:* DCs present allergen-derived peptides to T cells. Stimulation of allergen-specific T cells results in differentiation of CD4^+^ T cells into Th2 cells that produce Th2 cytokines. IL-4 directs T cell differentiation towards a Th2-related phenotype. IL-5 regulates the recruitment and differentiation of eosinophils and stimulates them to release mediators. Additionally, IL-4 and -13 induce Ig-class switching to IgE by B cells. IgEs bind to high affinity Fc*ε*RI on MCs. Sensitized, IL-9-activated, and maturated MCs degranulate and release preformed mediators, including histamine, leukotrienes, and prostaglandins. This allergic inflammatory cascade leads to increased mucus production, eosinophilia, bronchoconstriction, smooth-muscle contraction, and remodelling in the lungs, which result in allergic-airway hyperreactivity (AHR), airway inflammation or asthma. The allergic inflammation may be suppressed by a spill-over effect of immunomodulatory mechanisms of helminth infections.](JBB2011-821578.001){#fig1}

###### 

Helminth-derived immunomodulatory and Th2-inducing molecules. CXCL: chemokine ligand; DC: dendritic cell; Ig: immunoglobulin; GI: gastrointestinal; IFN-*γ*: interferon gamma; IL: interleukin; LPS: lipopolysaccharide; MAP: mitogen activated kinase; MHC: major histocompatibility complex; MIF: macrophage migration inhibitory factor; PBMC: peripheral blood mononuclear cell; STAT: signal transducer and activator of transcription; TGF: transforming growth factor; Th: T helper cell; TLR: Toll-like receptor; Treg: T regulatory cell.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Helminth species                 Name                                        Molecule                                                                                                                                                                                                                                Mechanisms of immune modulation during infection                                                                                                               Reference
  -------------------------------- ------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------
  *Echinococcus granulosus*        AgB                                         Antigen B                                                                                                                                                                                                                               Reduces expression of costimulatory molecules on human DCs and induces Th2                                                                                     \[[@B162]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Fasciola hepatica*              FheCL1                                      Cysteine protease                                                                                                                                                                                                                       Prevents release of macrophage inflammatory mediators by degrading TLR3                                                                                        \[[@B163]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Schistosoma mansoni*            Lyso-PS                                     Lyso-phosphatidylserine                                                                                                                                                                                                                 Lyso-PS treated DCs induce IL-10^+^ Treg through TLR2 and promote Th2 polarization                                                                             \[[@B66], [@B164]\]

  DsRNA                            Double-stranded RNA                         Triggers TLR3 to activate STAT1 and induces expression of type 1 IFNs in DCs                                                                                                                                                            \[[@B165], [@B166]\]                                                                                                                                           

  Omega-1                          Ribonuclease                                Reduces expression of costimulatory molecules and IL-12 in DCs and induces IL-4 and Foxp3 in CD4^+^ cells                                                                                                                               \[[@B67]--[@B167]\]                                                                                                                                            

  IPSE/alpha-1                     Glycoprotein                                Induces IgE-dependent IL-4 production from basophils in vivo                                                                                                                                                                            \[[@B168]\]                                                                                                                                                    

  SmCKBP                           Chemokine-binding protein                   Suppresses neutrophil recruitment by inhibiting the mammalian chemokine CXCL8                                                                                                                                                           \[[@B153]\]                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Ascaris suum*                   PAS-1                                       200 kDa protein                                                                                                                                                                                                                         Suppresses proinflammatory cytokines and neutrophil influx after exposure to LPS                                                                               \[[@B155]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Necator americanus*             *Na*-ASP-2                                  High homology to C-C chemokines                                                                                                                                                                                                         Secreted by infective larvae, recruits neutrophils in vitro and in vivo                                                                                        \[[@B128]\]

  *Na*-NES                         Metalloprotease                             Cleaves the eosinophil chemoattractant CCL11 and prevents its action in vitro and in vivo                                                                                                                                               \[[@B169]\]                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Nippostrongylus brasiliensis*   Acetylhydrolase                             Acetylhydrolase                                                                                                                                                                                                                         Inactivates mammalian platelet-activating factor, thus potentially regulating GI inflammation                                                                  \[[@B170]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Trichinella spiralis*           *Ts*-MIF                                    MIF homologue                                                                                                                                                                                                                           Inhibits migration of human PBMCs, similar to human MIF                                                                                                        \[[@B171]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Trichuris muris*                43 kDa IFN-*γ* homologue                    IFN-*γ* homologue                                                                                                                                                                                                                       Binds to IFN-*γ* receptor in mice                                                                                                                              \[[@B172]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Acanthocheilonema viteae*       AvCystatin /Av17                            Cysteine protease inhibitor                                                                                                                                                                                                             Downregulates T cell responses. Interferes with macrophage MAP kinase signaling pathways to induce IL-10                                                       \[[@B132], [@B133]\]

  ES-62                            Phosphorylcholine-containing glycoprotein   Reduces CD4^+^ T cell proliferation and IL-2 production, inhibits IL-4 and IL-13 production Inhibits IL-12 production from macrophages after exposure to LPS in a TLR4-dependent manner Induces an anti-inflammatory phenotype in DCs   \[[@B142]--[@B145]\]                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Brugia malayi*                  *Bm*-ALT-1,\                                Abundant larval transcript proteins                                                                                                                                                                                                     Expression of *Bm*-ALT in recombinant *Leishmania mexicana* parasites diminishes IFN-*γ*-mediated killing and induces GATA-3 and SOCS-1 in these macrophages   \[[@B173]\]
                                   *Bm*-ALT-2                                                                                                                                                                                                                                                                                                                                                                                                                                         

  *Bm*-CPI-2                       Cysteine protease inhibitor                 Blocks antigen presentation via MHC class II by interfering with asparaginyl endopeptidase                                                                                                                                              \[[@B130], [@B174]\]                                                                                                                                           

  *Bm*-TGH-2                       Homologue of TGF-*β*                        Binds to mammalian TGF-*β* receptors thus potentially influencing Treg differentiation                                                                                                                                                  \[[@B121]\]                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Litomosoides sigmodontis*       *Ls*-cystatin                               Cysteine protease inhibitor                                                                                                                                                                                                             Reduces antigen-specific proliferation of spleen cells                                                                                                         \[[@B135]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Onchocerca volvulus*            Onchocystatin                               Cysteine protease inhibitor                                                                                                                                                                                                             Suppresses antigen-specific proliferation of PBMCs, induces IL-10 from stimulated PBMCs\                                                                       \[[@B131], [@B175]\]
                                                                                                                                                                                                                                                                                                                       Reduces expression of MHC class II molecules and CD86 on human monocytes                                                                                       
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Effects of helminth infections and helminth-derived products/molecules on improvement of symptoms in allergy-related experimental animal models.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                       Allergy model                                                                         Suppressive mechanism                                                          Reference
  ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ -------------
  *Defined helminth molecules; (from helminth species)*                                                                                                                                                                                                     

                                                                                                                                                                                                                                                            

  smCKBP; (*S. mansoni*)                                                               Hapten-induced contact hypersensitivity                                               NA^3^                                                                          \[[@B153]\]

                                                                                                                                                                                                                                                            

  Sm22.6, PIII and Sm29; (*S. mansoni*)                                                OVA-induced AI^1^                                                                     CD4^+^Foxp3^+^ Treg                                                            \[[@B154]\]

                                                                                                                                                                                                                                                            

  *As*-MIF; (*A. simplex*)                                                             OVA-induced AI                                                                        IL-10, TGF-*β*, and Treg dependent                                             \[[@B127]\]

                                                                                                                                                                                                                                                            

  PAS-1; (*A. suum*)                                                                   APAS-3-induced AI                                                                     Possibly IL-10                                                                 \[[@B158]\]

  OVA-induced AHR^2^                                                                   CD4^+^CD25^+^ T cell-, CD8^+^ T cell-dependent and IL-10/TGF-*β*-, IFN-*γ*-mediated   \[[@B159], [@B160]\]                                                           

                                                                                                                                                                                                                                                            

  Nippocystatin (NbCys); (*N. brasiliensis*)                                           OVA-induced AI                                                                        Cathepsin B and cathepsin L-dependent mechanism                                \[[@B137]\]

                                                                                                                                                                                                                                                            

  AvCystatin (Av17); (*A. viteae*)                                                     OVA-induced AHR                                                                       IL-10, macrophages, partially CD4^+^CD25^+^ T cells                            \[[@B134]\]

                                                                                                                                                                                                                                                            

  ES-62; (*A. viteae*)                                                                 Oxazolone- (Oxa-) induced skin immediate hypersensitivity OVA-induced AHR             Mast cell mediated, TLR4-dependent                                             \[[@B147]\]

                                                                                                                                                                                                                                                            

  *Helminth infection and undefined products*                                                                                                                                                                                                               

                                                                                                                                                                                                                                                            

  *S. mansoni*infection; males and females + eggs laid in infection; males (no eggs)   Pen V-induced systemic anaphylaxis                                                    IL-10-producing B cells                                                        \[[@B108]\]

                                                                                                                                                                                                                                                            

  *S. mansoni*infection; males (no eggs)                                               OVA-induced AHR                                                                       B cell- and IL-10-dependent suppression of pulmonary eosinophil infiltration   \[[@B109]\]

                                                                                                                                                                                                                                                            

  *S. mansoni*infection; eggs                                                          OVA-induced AI                                                                        Egg-treatment: CD4^+^CD25^+^Foxp3^+^Treg                                       \[[@B111]\]

                                                                                                                                                                                                                                                            

  *S. japonicum*egg antigen (SEA)                                                      OVA-induced AI                                                                        CD4^+^CD25^+^ Treg, possibly IL-10                                             \[[@B152]\]

                                                                                                                                                                                                                                                            

  *A. suum* adult worm extract (ASC)                                                   OVA-induced AHR                                                                       NA                                                                             \[[@B176]\]

                                                                                                                                                                                                                                                            

  *Heligmosomoides polygyrus* infection                                                OVA-induced AHR                                                                       IL-10                                                                          \[[@B113]\]

  OVA-induced AHR\                                                                     IL-10-independent, CD4^+^CD25^+^ T cells\                                             \[[@B119], [@B110]\]                                                           
  HDM-induced AI                                                                       IL-10-independent Breg cells                                                                                                                                         

  Peanut extract-induced food allergy                                                  IL-10                                                                                 \[[@B114]\]                                                                    

                                                                                                                                                                                                                                                            

  *H. polygyrus* excretory-secretory product (HES)                                     OVA-induced AI                                                                        HES-induced Treg cells                                                         \[[@B97]\]

                                                                                                                                                                                                                                                            

  *N. brasiliensis*infection                                                           OVA-induced AHR                                                                       IL-10 from unknown cell source                                                 \[[@B115]\]

                                                                                                                                                                                                                                                            

  *N. brasiliensis*excretory-secretory product (NES)                                   OVA-induced AI                                                                        NA (IL-10 independent)                                                         \[[@B118]\]

                                                                                                                                                                                                                                                            

  *Strongyloides stercoralis*infection                                                 OVA-induced AI                                                                        NA                                                                             \[[@B177]\]

                                                                                                                                                                                                                                                            

  *Strongyloides venezuelensis*infection                                               OVA-induced AI                                                                        NA                                                                             \[[@B178]\]

                                                                                                                                                                                                                                                            

  *T. spiralis* infection                                                              OVA-induced AI                                                                        Correlated with increased IL-10, TGF-*β*, CD4^+^CD25^+^ Treg                   \[[@B116]\]

                                                                                                                                                                                                                                                            

  *L. sigmodontis*infection                                                            OVA-induced AHR                                                                       TGF-*β*, CD4^+^CD25^+^ Treg                                                    \[[@B117]\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ (AI): airway inflammation, associated with inflammatory cell influx into the lungs and local Th2 cytokine production.

^2^ (AHR): airway hyperreactivity, mainly described as lung bronchiole and smooth-muscle tissue remodelling leading to airflow obstruction, resulting in altered airway function. Chronic airway inflammation may lead to AHR, however, different immunopathological pathways govern the regulation of AI and AHR (discussed elsewhere \[[@B179]--[@B183]\]).

^3^NA data not available.
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